Search results
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 7 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Macron’s Call for Elections in France Adds to Fears of Financial Woes
New York Times· 9 hours agoInvestors made clear on Tuesday the depth of their concerns over President Emmanuel Macron’s gamble...
Stocks of Local Interest
Clinton Herald, Iowa· 1 day agoJun. 10—Closing prices Monday: Adv Auto Parts 63.19 Abbott Labs 107.49 ADM 61.97 Ameriprise 428.47 AutoZone, Inc. 2,619.41 Boeing 190.12 Bank of America 39.67 BP PLC ADR 35.92 ConAgra Foods ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
My 3 Top Stocks to Buy in June
247wallst.com· 7 days ago24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE:...
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal - Vanda Pharma...
Benzinga· 6 days agoVanda Pharmaceuticals Inc. VNDA received an acquisition offer from Cycle Pharmaceuticals Ltd worth $8 per share, representing a total cash consideration of $466 million. In May, Cycle launched ...
FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall (NYSE:PFE)
Seeking Alpha· 6 days agoA panel of advisors unanimously agrees on the need for a monovalent COVID-19 shot targeting the JN.1...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 2 days agoGSK currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 6 days agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 15 hours agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
